Psychedelic therapy under the microscope: did intensity matter?
NCT ID NCT07164287
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 31 times
Summary
This study reviewed medical records of 376 people who received LSD or psilocybin therapy for hard-to-treat depression, anxiety, or addiction. Researchers wanted to see if the intensity of the psychedelic experience was linked to better outcomes. No new treatments were given—only existing data was analyzed to learn more about how this therapy works in real-world clinics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Geneva University Hospital
Geneva, Switzerland
Conditions
Explore the condition pages connected to this study.